Results 261 to 270 of about 188,637 (301)

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC

Nature Reviews Clinical Oncology, 2021
Roy S Herbst, Sarah B Goldberg
exaly  

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
, Florian Castet, Mala K Maini
exaly  

Anti-tuberculosis treatment strategies and drug development: challenges and priorities

Nature Reviews Microbiology, 2022
Véronique A Dartois, Eric J Rubin
exaly  

Aminoglycoside Dosage Regimens

Clinical Pharmacokinetics, 1993
Hustinx, WNM, Hoepelman, IM
openaire   +3 more sources

Dosage Regimens of Antibacterials

Clinical Drug Investigation, 1996
Michel J.Y. Bouvier dʼYvoire, Pascal H. Maire   +1 more
openaire   +1 more source

Dosage Regimen

2020
openaire   +1 more source

Influence of Dosage Regimen

Journal of Infectious Diseases, 1980
openaire   +2 more sources

OPTIMUM PHENYTOIN-DOSAGE REGIMENS

The Lancet, 1976
T.M. Ludden, D.W. Hawkins, J.P. Allen, S.F. Hoffman   +3 more
openaire   +1 more source

ESTIMATING DRUG-DOSAGE REGIMENS

The Lancet, 1969
J.H. Darrell, PamelaM. Waterworth, D.A. Mitchison, Wallace Fox, J.S. Orr, J. Shimmins, C.F. Speirs   +6 more
openaire   +1 more source

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly